The Claim
The precision of estimating the progression rate of breast cancer (λ) is highly sensitive to the duration of clinical follow-up after the final screening, such that short follow-up periods result in practically nonidentifiable parameters due to insufficient observation of the tail of the progression time distribution.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
If doctors don't keep an eye on breast cancer patients long enough after their last screening, they can't tell how fast the cancer is likely to grow — it's like trying to guess how long a candle will burn by only watching it for a few seconds.
See the scientific wording
The precision of estimating the progression rate of breast cancer (λ) is highly sensitive to the duration of clinical follow-up after the final screening, with short follow-up leading to practically nonidentifiable parameters due to insufficient observation of the tail of the progression time distribution.
What the research says
1 studyThis study found that if doctors don’t watch patients long enough after their last breast cancer screen, they can’t tell how fast the cancer would grow — just like trying to guess how long a plant takes to die without watching it long enough.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.